Least chance of receipient failure in transplant is seen in –
**Core Concept**
The question is testing the concept of graft survival and recipient failure in the context of organ transplantation. Graft survival is influenced by various factors, including immunological compatibility between the donor and recipient, the presence of underlying medical conditions in the recipient, and the use of immunosuppressive medications.
**Why the Correct Answer is Right**
The correct answer is related to the use of immunosuppressive medications, specifically the concept of "primary non-function" (PNF) and "acute rejection" (AR). Primary non-function refers to the failure of a graft to function immediately after transplantation, whereas acute rejection is an immune response against the graft that occurs within the first few weeks or months after transplantation. The use of certain immunosuppressive medications, such as calcineurin inhibitors (CNIs), has been shown to reduce the risk of acute rejection and improve graft survival.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify which type of transplant or recipient condition would have the least chance of recipient failure. Without more information, it is difficult to determine which option is correct.
**Option B:** This option is incorrect because it implies that the type of donor (e.g., living versus deceased) is the primary factor in determining graft survival. While donor type is an important consideration, it is not the only factor.
**Option C:** This option is incorrect because it suggests that the use of a specific immunosuppressive medication (e.g., corticosteroids) is the primary factor in reducing recipient failure. While corticosteroids are commonly used in transplantation, they are not the only medication that can reduce recipient failure.
**Clinical Pearl / High-Yield Fact**
One key point to remember is that the use of calcineurin inhibitors (CNIs) has been shown to reduce the risk of acute rejection and improve graft survival in solid organ transplantation. CNIs work by inhibiting the activity of calcineurin, a protein that plays a key role in the activation of T-lymphocytes, which are responsible for the immune response against the graft.
**Correct Answer: C. The use of calcineurin inhibitors (CNIs) has been shown to reduce the risk of acute rejection and improve graft survival in solid organ transplantation.**